US/UK/Canada

Share

Contacts

  • UPM Media Desk
    http://upm.com
    • Pick a time period -
    Tags ( Active)

    Wound dressing FibDex® to be clinically tested for treatment of superficial dermal burns

    (UPM, Helsinki, 22 June 2023 at 12:00 EEST) – UPM Biomedicals’ innovative wound dressing FibDex is undergoing a clinical investigation of performance and safety in patients with superficial dermal burns. The clinical investigation will be conducted by the Burn Centre of Uppsala University Hospital, Sweden, and is estimated to be completed in the beginning of the year 2025. UPM Biomedicals has previously prepared all the required protocols and other documents and received the regulatory and ethical approvals. The clinical investigation has started with Fredrik Huss (MD, PhD, Assoc.

    UPM Biomedicals and Cellbox in collaboration to provide a live cell shipment solution

    (UPM, Helsinki, 19 October 2021 at 13:00 EET) – UPM Biomedicals and Cellbox have signed an agreement for providing a unique live cell shipment solution. The plant derived and animal-free transport technology for living cell and tissue cultures allows shipping of live 3D cell assays between researchers and pharmaceutical companies. Combining UPM’s nanocellulose based hydrogel and Cellbox’s portable CO\2\ incubator offers protection from mechanical stress and maintains cell activity during transportation. It facilitates the transport of the most complex and sensitive cell cultures with the

    UPM Biomedicals and PerkinElmer collaborate to offer high throughput 3D cell screening solution

    UPM Biomedicals and PerkinElmer collaborate to offer high throughput 3D cell screening solution (UPM, Helsinki, 29 September 2021 at 16:00 EET) – UPM Biomedicals is pleased to announce that it has entered into an agreement with PerkinElmer Health Sciences, Inc., for the life science leader, to act as a distributor of the UPM GrowDex ® and GrowDase ™ range of products. This new collaboration will offer researchers a complete solution for high throughput screening (

    UPM brings its first clinical product to market – FibDex® wound dressing

    (UPM, Helsinki, 20.8.2020 at 10:00 EET) FibDex[®] wound dressing – made from nanofibrillar cellulose by UPM Biomedicals – has taken a significant step in its path to market, as leading medical device distributor Steripolar Oy now sells the product in Finland. FibDex is the first clinical product of renowned forest-based bioindustry company UPM and shows promising signs for future developments, such as cell therapy. ”We are excited to offer this Finnish product, made from Finnish raw material, first in the world to Finnish healthcare professionals and patients,” said Johana Kuncova-Kallio,

    There are no items matching the current filter
    There are no more items matching the current filter
    Back to top

    Subscribe

    Media